Cargando…
Activation of Haem-Oxidized Soluble Guanylyl Cyclase with BAY 60-2770 in Human Platelets Lead to Overstimulation of the Cyclic GMP Signaling Pathway
BACKGROUND AND AIMS: Nitric oxide-independent soluble guanylyl cyclase (sGC) activators reactivate the haem-oxidized enzyme in vascular diseases. This study was undertaken to investigate the anti-platelet mechanisms of the haem-independent sGC activator BAY 60-2770 in human washed platelets. The hyp...
Autores principales: | Mendes-Silverio, Camila B., Leiria, Luiz O. S., Morganti, Rafael P., Anhê, Gabriel F., Marcondes, Sisi, Mónica, Fabíola Z., De Nucci, Gilberto, Antunes, Edson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493568/ https://www.ncbi.nlm.nih.gov/pubmed/23144808 http://dx.doi.org/10.1371/journal.pone.0047223 |
Ejemplares similares
-
The soluble guanylyl cyclase activator BAY 60-2770 ameliorates detrusor dysfunction in obese mice
por: de Nucci, Gilberto, et al.
Publicado: (2013) -
Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation
por: Hoffmann, Linda Sarah, et al.
Publicado: (2009) -
Signaling via guanylyl cyclase C: cGMP, Src and p21
por: Basu, Nirmalya, et al.
Publicado: (2011) -
Comparative Studies of the Dynamics Effects of BAY60-2770 and BAY58-2667 Binding with Human and Bacterial H-NOX Domains
por: Rehan Khalid, Rana, et al.
Publicado: (2018) -
Receptor Guanylyl Cyclase C and Cyclic GMP in Health and Disease: Perspectives and Therapeutic Opportunities
por: Prasad, Hari, et al.
Publicado: (2022)